Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- Check5 days agoChange DetectedPage revision updated to v3.6.6, indicating a deployment/refresh of the study page. This reflects a maintenance or metadata update rather than a substantive change to study details or eligibility.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of Revision: v3.6.4, indicating a software version update for the site. No study details or content are altered as a result.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor update to the page's revision history. This change does not alter study data, eligibility criteria, or user-facing content.SummaryDifference0.1%

- Check69 days agoChange DetectedFooter/credits now include the Moffitt Cancer Center Clinical Trials website and the full institutional name, and the site revision is updated from v3.6.0 to v3.6.3.SummaryDifference0.2%

- Check83 days agoChange DetectedThe page now reflects that recruitment has ceased for participants, indicating the study is not actively enrolling. Added help and navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with minor formatting changes to the Intervention/Treatment label and a revision tag updated to v3.6.0.SummaryDifference0.4%

- Check90 days agoChange DetectedThe page's revision stamp was updated from v3.5.4 to v3.5.5. This update modifies version metadata and does not change study details or user-visible content.SummaryDifference0.1%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.